Other substances

Rolapitant

A neurokinin-1 receptor antagonist.

Phase of research

Potential treatment - theoretical effect

How it helps

Antiviral

Drug status

Used to treat other disease

1
 Supporting references
0
 Contradictory references
1
 AI-suggested references
0
 Clinical trials

General information

Rolapitant on PubChem

Marketed as

VARUBI

 

Structure image - Rolapitant

C[C@H](C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC[C@]2(CC[C@]3(CCC(=O)N3)CN2)C4=CC=CC=C4


 

Supporting references

Link Tested on Impact factor Notes Publication date
Computational molecular docking and virtual screening revealed promising SARS-CoV-2 drugs
3CLpro PapainLpro RdRpol Small molecule In silico 		in silico

Predicted to inhibit SARS-CoV-2 3C-like protease.

 Jan/18/2021

AI-suggested references

Link Publication date
Community Birth: The Value of Collaboration.
Oct/29/2020
Export (.csv)